Xenobiotic-induced hepatotoxicity: Mechanisms of liver injury and methods of monitoring hepatic function

Clinical Chemistry

Volumn 43, Issue 8 SUPPL., 1997, Pages 1512-1526

  Sturgill, Marc G ^a,b   Lambert, George H ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Ccytochrome P450 enzymes; Cytotoxic cholestatic liver injury; Liver function tests; Xenobiotic metabolism

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMINOPHENAZONE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; CYTOCHROME P450; GAMMA GLUTAMYLTRANSFERASE; PHENAZONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE PREDISPOSITION; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; LIVER CLEARANCE; LIVER FUNCTION; LIVER INJURY; LIVER TOXICITY; PATHOPHYSIOLOGY; PATIENT MONITORING; PROTHROMBIN TIME; TOXIC HEPATITIS; XENOBIOTIC METABOLISM;

EID: 0030753864     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.8.1512     Document Type: Conference Paper

References (13)

1. Bass NM, Ockner BA. Drug-induced liver disease. In: Zakin D, Boyer TD, eds. Hepatology: a textbook of liver disease, 3rd ed. Philadelphia: WB Saunders, 1996:962-1017.
2. Lewis JH, Zimmerman HJ. Drug-induced liver disease. Med Clin North Am 1989;73:775-92.
3. Werth B, Kuhn M, Hartmann K, Kobler E, Reinhart WH. Drug-induced liver disease: experiences of the Swiss Center for Adverse Drug Effects 1989-91. J Suisse Med 1993;123:1203-6.
4. Jones AL. Anatomy of the normal liver. In: Zakin D, Boyer TD, eds. Hepatology: a textbook of liver disease, 3rd ed. Philadelphia: WB Saunders, 1996:3-32.
5. Rappaport AM, Wanless IR. Anatomic considerations. In: Schiff L, Schiff ER, eds. Diseases of the liver, 7th ed. Philadelphia: JB Lippincott, 1993:1-41.
6. Thurman RG, Kauffman FC, Baron J. Biotransformation and zonal toxicity. In: Thurman RG, Kauffman FC, Jurngerman K, eds. Regulation of hepatic metabolism: intra- and intercellular compartmentalization. New York: Plenum, 1986:321-82.
7. Vessey DA. Metabolism of xenobiotics by the human liver. In: Zakin D, Boyer TD, eds. Hepatology: a textbook of liver disease, 3rd ed. Philadelphia: WB Saunders, 1996:257-305.
8. Dahm U, Jones DP. Mechanisms of chemically induced liver disease. In: Zakin D, Boyer TD, eds. Hepatology: a textbook of liver disease, 3rd ed. Philadelphia: WB Saunders, 1996:875-90.
9. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 1995;333:1118-27.
10. Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am 1992;21:511-26.
11. Bernhardt R. Cytochrome P450: structure, function, and generation of reactive oxygen species. Rev Biochem Pharmacol 1995; 127:137-221.
12. Bellomo G, Orrenius S. Altered thiol and calcium homeostasis in oxidative hepatocellular injury. Hepatology 1985;5:876-82.
13. Thor H, Orrenius S. The mechanism of bromobenzene-induced cytotoxicity studied with isolated hepatocytes. Arch Toxicol 1980;44:31-43.